CEVA sell-off overdone, says Oppenheimer


Oppenheimer believes that Q3 will mark an earnings trough for CEVA, and the firm thinks that momentum is building in the company's key market, China. The firm recommends buying the stock ahead of the company's Q3 results and it maintains a $25 target and Outperform rating on the stock.

View Comments (0)